Literature DB >> 28327952

Risk of Venous Thromboembolism and Operative Duration in Patients Undergoing Neurosurgical Procedures.

Kimon Bekelis1,2, Nicos Labropoulos3, Shannon Coy4.   

Abstract

BACKGROUND: The association of operative duration with the risk of venous thromboembolism (VTE) has not been quantified in neurosurgery.
OBJECTIVE: To investigate the association of surgical duration for several neurosurgical procedures and the incidence of VTE.
METHODS: We performed a retrospective cohort study involving patients who underwent neurosurgical procedures from 2005 to 2012 and were registered in the American College of Surgeons National Quality Improvement Project registry. In order to control for confounding, we used multivariable regression models, and propensity score conditioning.
RESULTS: During the study period, there were 94 747 patients, who underwent neurosurgical procedures, and met the inclusion criteria. Of these, 1358 (1.0%) developed VTE within 30 days postoperatively. Multivariable logistic regression demonstrated an association of longer operative duration with higher 30-day incidence of VTE (odds ratio [OR], 1.22; 95% confidence interval [CI], 1.19-1.25). Compared with procedures of moderate duration (third quintile, 40-60th percentile), patients undergoing the longest procedures (>80th percentile) had higher odds (OR, 3.15; 95% CI, 2.49-3.99) of developing VTE. The shortest procedures (<20th percentile) were associated with a decreased incidence of VTE (OR, 0.51; 95% CI, 0.27-0.76) in comparison to those of moderate duration. The same associations were present in propensity score-adjusted models, and models stratified by subgroups of cranial, spinal, peripheral nerve, and carotid procedures.
CONCLUSIONS: In a cohort of patients from a national prospective surgical registry, increased operative duration was associated with increased incidence of VTE for neurosurgical procedures. These results can be used by neurosurgeons to inform operative management, and to stratify patients with regard to VTE risk.
Copyright © 2016 by the Congress of Neurological Surgeons

Entities:  

Keywords:  DVT; NSQIP; Neurosurgery; Operative duration; PE; VTE

Mesh:

Year:  2017        PMID: 28327952     DOI: 10.1093/neuros/nyw129

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  6 in total

1.  Retrosigmoid Transtentorial Approach Compared to Traditional Transpetrosal Approaches for the Resection of Petroclival Meningiomas: A Case-Control Study.

Authors:  Ribhu T Jha; Paul McBride; Gleb Zavadskiy; Harry R van Loveren; Siviero Agazzi
Journal:  J Neurol Surg B Skull Base       Date:  2020-06-19

2.  Risk factors for venous thromboembolism and evaluation of the modified Caprini score in patients undergoing lung resection.

Authors:  Songping Cui; Shuo Chen; Hui Li; Lihui Ke; Yi Liu; Ruiheng Jiang; Bin Hu; Tong Li; Yang Wang; Jinbai Miao; Wenqian Zhang
Journal:  J Thorac Dis       Date:  2020-09       Impact factor: 2.895

3.  The combination of Caprini risk assessment scale and thrombotic biomarkers to evaluate the risk of venous thromboembolism in critically ill patients.

Authors:  Yang Fu; Yumei Liu; Si Chen; Yaxiong Jin; Hong Jiang
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

4.  Venous thromboembolism following inpatient pediatric surgery: Analysis of 153,220 patients.

Authors:  Brandon A Sherrod; Samuel G McClugage; Vincent E Mortellaro; Inmaculada B Aban; Brandon G Rocque
Journal:  J Pediatr Surg       Date:  2018-10-10       Impact factor: 2.545

5.  Work relative value units and perioperative outcomes in patients undergoing brain tumor surgery.

Authors:  Robert B Kim; Jonathan P Scoville; Michael Karsy; Seokchun Lim; Randy L Jensen; Sarah T Menacho
Journal:  Neurosurg Rev       Date:  2021-07-08       Impact factor: 3.042

6.  Comparison of a pressure-sensing sheath and radial arterial line for intraoperative blood pressure monitoring in neurointerventional procedures.

Authors:  Michael T Froehler; Rohan Chitale; Jordan A Magarik; Matthew R Fusco
Journal:  J Neurointerv Surg       Date:  2018-02-27       Impact factor: 5.836

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.